Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Investment

Regal slashes holdings in Opthea over insolvency concerns

Regal Asian Investments (ASX:RG8) has significantly devalued its holdings in biopharmaceutical company Opthea after the latter flagged insolvency concerns amid the failure of a major clinical trial.

Upgrade your subscription to access this article

And gain access to:
  • All website content, including archived news
  • Home page news customisation
  • Tech Zone, your technical resource library
And more
Already A Subscriber?

Read more: OPT,  Opthea,  RG8,  Nasdaq,  Aflibercept Study,  Corporations Act,  Development Funding Agreement Investors,  Regal Asian Investments Management